Table of Content

1 Study Coverage
1.1 Pharyngitis Drug Product Introduction
1.2 Market by Type
1.2.1 Global Pharyngitis Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Spray
1.2.5 Solution
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pharyngitis Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharyngitis Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Pharyngitis Drug Revenue by Region
2.2.1 Global Pharyngitis Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pharyngitis Drug Revenue by Region (2018-2024)
2.2.3 Global Pharyngitis Drug Revenue by Region (2024-2029)
2.2.4 Global Pharyngitis Drug Revenue Market Share by Region (2018-2029)
2.3 Global Pharyngitis Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Pharyngitis Drug Sales by Region
2.4.1 Global Pharyngitis Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pharyngitis Drug Sales by Region (2018-2024)
2.4.3 Global Pharyngitis Drug Sales by Region (2024-2029)
2.4.4 Global Pharyngitis Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pharyngitis Drug Sales by Manufacturers
3.1.1 Global Pharyngitis Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Pharyngitis Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharyngitis Drug in 2022
3.2 Global Pharyngitis Drug Revenue by Manufacturers
3.2.1 Global Pharyngitis Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Pharyngitis Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pharyngitis Drug Revenue in 2022
3.3 Global Key Players of Pharyngitis Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Pharyngitis Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pharyngitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pharyngitis Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pharyngitis Drug, Product Offered and Application
3.8 Global Key Manufacturers of Pharyngitis Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharyngitis Drug Sales by Type
4.1.1 Global Pharyngitis Drug Historical Sales by Type (2018-2024)
4.1.2 Global Pharyngitis Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Pharyngitis Drug Sales Market Share by Type (2018-2029)
4.2 Global Pharyngitis Drug Revenue by Type
4.2.1 Global Pharyngitis Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Pharyngitis Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pharyngitis Drug Revenue Market Share by Type (2018-2029)
4.3 Global Pharyngitis Drug Price by Type
4.3.1 Global Pharyngitis Drug Price by Type (2018-2024)
4.3.2 Global Pharyngitis Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pharyngitis Drug Sales by Application
5.1.1 Global Pharyngitis Drug Historical Sales by Application (2018-2024)
5.1.2 Global Pharyngitis Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Pharyngitis Drug Sales Market Share by Application (2018-2029)
5.2 Global Pharyngitis Drug Revenue by Application
5.2.1 Global Pharyngitis Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Pharyngitis Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pharyngitis Drug Revenue Market Share by Application (2018-2029)
5.3 Global Pharyngitis Drug Price by Application
5.3.1 Global Pharyngitis Drug Price by Application (2018-2024)
5.3.2 Global Pharyngitis Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pharyngitis Drug Market Size by Type
6.1.1 US & Canada Pharyngitis Drug Sales by Type (2018-2029)
6.1.2 US & Canada Pharyngitis Drug Revenue by Type (2018-2029)
6.2 US & Canada Pharyngitis Drug Market Size by Application
6.2.1 US & Canada Pharyngitis Drug Sales by Application (2018-2029)
6.2.2 US & Canada Pharyngitis Drug Revenue by Application (2018-2029)
6.3 US & Canada Pharyngitis Drug Market Size by Country
6.3.1 US & Canada Pharyngitis Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pharyngitis Drug Sales by Country (2018-2029)
6.3.3 US & Canada Pharyngitis Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pharyngitis Drug Market Size by Type
7.1.1 Europe Pharyngitis Drug Sales by Type (2018-2029)
7.1.2 Europe Pharyngitis Drug Revenue by Type (2018-2029)
7.2 Europe Pharyngitis Drug Market Size by Application
7.2.1 Europe Pharyngitis Drug Sales by Application (2018-2029)
7.2.2 Europe Pharyngitis Drug Revenue by Application (2018-2029)
7.3 Europe Pharyngitis Drug Market Size by Country
7.3.1 Europe Pharyngitis Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pharyngitis Drug Sales by Country (2018-2029)
7.3.3 Europe Pharyngitis Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pharyngitis Drug Market Size
8.1.1 China Pharyngitis Drug Sales (2018-2029)
8.1.2 China Pharyngitis Drug Revenue (2018-2029)
8.2 China Pharyngitis Drug Market Size by Application
8.2.1 China Pharyngitis Drug Sales by Application (2018-2029)
8.2.2 China Pharyngitis Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pharyngitis Drug Market Size by Type
9.1.1 Asia Pharyngitis Drug Sales by Type (2018-2029)
9.1.2 Asia Pharyngitis Drug Revenue by Type (2018-2029)
9.2 Asia Pharyngitis Drug Market Size by Application
9.2.1 Asia Pharyngitis Drug Sales by Application (2018-2029)
9.2.2 Asia Pharyngitis Drug Revenue by Application (2018-2029)
9.3 Asia Pharyngitis Drug Sales by Region
9.3.1 Asia Pharyngitis Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pharyngitis Drug Revenue by Region (2018-2029)
9.3.3 Asia Pharyngitis Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pharyngitis Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Pharyngitis Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pharyngitis Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pharyngitis Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Pharyngitis Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pharyngitis Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pharyngitis Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Pharyngitis Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pharyngitis Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pharyngitis Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Genentech Inc
11.1.1 Genentech Inc Company Information
11.1.2 Genentech Inc Overview
11.1.3 Genentech Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Genentech Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Genentech Inc Recent Developments
11.2 Adamas Pharmaceutical Inc
11.2.1 Adamas Pharmaceutical Inc Company Information
11.2.2 Adamas Pharmaceutical Inc Overview
11.2.3 Adamas Pharmaceutical Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Adamas Pharmaceutical Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Adamas Pharmaceutical Inc Recent Developments
11.3 PLIVA HRVATSKA d.o.o
11.3.1 PLIVA HRVATSKA d.o.o Company Information
11.3.2 PLIVA HRVATSKA d.o.o Overview
11.3.3 PLIVA HRVATSKA d.o.o Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 PLIVA HRVATSKA d.o.o Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 PLIVA HRVATSKA d.o.o Recent Developments
11.4 Pfizer Inc
11.4.1 Pfizer Inc Company Information
11.4.2 Pfizer Inc Overview
11.4.3 Pfizer Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Inc Recent Developments
11.5 Valeant Pharmaceuticals International, Inc
11.5.1 Valeant Pharmaceuticals International, Inc Company Information
11.5.2 Valeant Pharmaceuticals International, Inc Overview
11.5.3 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Valeant Pharmaceuticals International, Inc Recent Developments
11.6 Mylan N.V
11.6.1 Mylan N.V Company Information
11.6.2 Mylan N.V Overview
11.6.3 Mylan N.V Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Mylan N.V Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan N.V Recent Developments
11.7 GSK group of companies
11.7.1 GSK group of companies Company Information
11.7.2 GSK group of companies Overview
11.7.3 GSK group of companies Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 GSK group of companies Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GSK group of companies Recent Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Teva Pharmaceutical Industries Ltd Company Information
11.8.2 Teva Pharmaceutical Industries Ltd Overview
11.8.3 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.9 AbbVie Inc
11.9.1 AbbVie Inc Company Information
11.9.2 AbbVie Inc Overview
11.9.3 AbbVie Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 AbbVie Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AbbVie Inc Recent Developments
11.10 Viatris Inc. (Mylan)
11.10.1 Viatris Inc. (Mylan) Company Information
11.10.2 Viatris Inc. (Mylan) Overview
11.10.3 Viatris Inc. (Mylan) Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Viatris Inc. (Mylan) Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Viatris Inc. (Mylan) Recent Developments
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Company Information
11.11.2 GlaxoSmithKline plc Overview
11.11.3 GlaxoSmithKline plc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 GlaxoSmithKline plc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GlaxoSmithKline plc Recent Developments
11.12 Abbott Laboratories
11.12.1 Abbott Laboratories Company Information
11.12.2 Abbott Laboratories Overview
11.12.3 Abbott Laboratories Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Abbott Laboratories Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Abbott Laboratories Recent Developments
11.13 Amgen Inc
11.13.1 Amgen Inc Company Information
11.13.2 Amgen Inc Overview
11.13.3 Amgen Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Amgen Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Amgen Inc Recent Developments
11.14 Sanofi-aventis Groupe
11.14.1 Sanofi-aventis Groupe Company Information
11.14.2 Sanofi-aventis Groupe Overview
11.14.3 Sanofi-aventis Groupe Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Sanofi-aventis Groupe Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sanofi-aventis Groupe Recent Developments
11.15 Purdue Pharma L.P
11.15.1 Purdue Pharma L.P Company Information
11.15.2 Purdue Pharma L.P Overview
11.15.3 Purdue Pharma L.P Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Purdue Pharma L.P Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Purdue Pharma L.P Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pharyngitis Drug Industry Chain Analysis
12.2 Pharyngitis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharyngitis Drug Production Mode & Process
12.4 Pharyngitis Drug Sales and Marketing
12.4.1 Pharyngitis Drug Sales Channels
12.4.2 Pharyngitis Drug Distributors
12.5 Pharyngitis Drug Customers
13 Market Dynamics
13.1 Pharyngitis Drug Industry Trends
13.2 Pharyngitis Drug Market Drivers
13.3 Pharyngitis Drug Market Challenges
13.4 Pharyngitis Drug Market Restraints
14 Key Findings in The Global Pharyngitis Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pharyngitis Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Major Manufacturers of Spray
Table 5. Major Manufacturers of Solution
Table 6. Major Manufacturers of Other
Table 7. Global Pharyngitis Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Pharyngitis Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Pharyngitis Drug Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Pharyngitis Drug Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Pharyngitis Drug Revenue Market Share by Region (2018-2024)
Table 12. Global Pharyngitis Drug Revenue Market Share by Region (2024-2029)
Table 13. Global Pharyngitis Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Pharyngitis Drug Sales by Region (2018-2024) & (K Units)
Table 15. Global Pharyngitis Drug Sales by Region (2024-2029) & (K Units)
Table 16. Global Pharyngitis Drug Sales Market Share by Region (2018-2024)
Table 17. Global Pharyngitis Drug Sales Market Share by Region (2024-2029)
Table 18. Global Pharyngitis Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Pharyngitis Drug Sales Share by Manufacturers (2018-2024)
Table 20. Global Pharyngitis Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Pharyngitis Drug Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Pharyngitis Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Pharyngitis Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Pharyngitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pharyngitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharyngitis Drug as of 2022)
Table 26. Global Key Manufacturers of Pharyngitis Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Pharyngitis Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Pharyngitis Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pharyngitis Drug Sales by Type (2018-2024) & (K Units)
Table 31. Global Pharyngitis Drug Sales by Type (2024-2029) & (K Units)
Table 32. Global Pharyngitis Drug Sales Share by Type (2018-2024)
Table 33. Global Pharyngitis Drug Sales Share by Type (2024-2029)
Table 34. Global Pharyngitis Drug Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Pharyngitis Drug Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Pharyngitis Drug Revenue Share by Type (2018-2024)
Table 37. Global Pharyngitis Drug Revenue Share by Type (2024-2029)
Table 38. Pharyngitis Drug Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Pharyngitis Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Pharyngitis Drug Sales by Application (2018-2024) & (K Units)
Table 41. Global Pharyngitis Drug Sales by Application (2024-2029) & (K Units)
Table 42. Global Pharyngitis Drug Sales Share by Application (2018-2024)
Table 43. Global Pharyngitis Drug Sales Share by Application (2024-2029)
Table 44. Global Pharyngitis Drug Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Pharyngitis Drug Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Pharyngitis Drug Revenue Share by Application (2018-2024)
Table 47. Global Pharyngitis Drug Revenue Share by Application (2024-2029)
Table 48. Pharyngitis Drug Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Pharyngitis Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Pharyngitis Drug Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Pharyngitis Drug Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Pharyngitis Drug Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Pharyngitis Drug Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Pharyngitis Drug Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Pharyngitis Drug Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Pharyngitis Drug Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Pharyngitis Drug Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Pharyngitis Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Pharyngitis Drug Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Pharyngitis Drug Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Pharyngitis Drug Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Pharyngitis Drug Sales by Country (2024-2029) & (K Units)
Table 63. Europe Pharyngitis Drug Sales by Type (2018-2024) & (K Units)
Table 64. Europe Pharyngitis Drug Sales by Type (2024-2029) & (K Units)
Table 65. Europe Pharyngitis Drug Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Pharyngitis Drug Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Pharyngitis Drug Sales by Application (2018-2024) & (K Units)
Table 68. Europe Pharyngitis Drug Sales by Application (2024-2029) & (K Units)
Table 69. Europe Pharyngitis Drug Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Pharyngitis Drug Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Pharyngitis Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Pharyngitis Drug Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Pharyngitis Drug Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Pharyngitis Drug Sales by Country (2018-2024) & (K Units)
Table 75. Europe Pharyngitis Drug Sales by Country (2024-2029) & (K Units)
Table 76. China Pharyngitis Drug Sales by Type (2018-2024) & (K Units)
Table 77. China Pharyngitis Drug Sales by Type (2024-2029) & (K Units)
Table 78. China Pharyngitis Drug Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Pharyngitis Drug Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Pharyngitis Drug Sales by Application (2018-2024) & (K Units)
Table 81. China Pharyngitis Drug Sales by Application (2024-2029) & (K Units)
Table 82. China Pharyngitis Drug Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Pharyngitis Drug Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Pharyngitis Drug Sales by Type (2018-2024) & (K Units)
Table 85. Asia Pharyngitis Drug Sales by Type (2024-2029) & (K Units)
Table 86. Asia Pharyngitis Drug Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Pharyngitis Drug Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Pharyngitis Drug Sales by Application (2018-2024) & (K Units)
Table 89. Asia Pharyngitis Drug Sales by Application (2024-2029) & (K Units)
Table 90. Asia Pharyngitis Drug Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Pharyngitis Drug Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Pharyngitis Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Pharyngitis Drug Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Pharyngitis Drug Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Pharyngitis Drug Sales by Region (2018-2024) & (K Units)
Table 96. Asia Pharyngitis Drug Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Pharyngitis Drug Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Pharyngitis Drug Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Pharyngitis Drug Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Pharyngitis Drug Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Pharyngitis Drug Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Pharyngitis Drug Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Pharyngitis Drug Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pharyngitis Drug Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pharyngitis Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Pharyngitis Drug Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pharyngitis Drug Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Pharyngitis Drug Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Pharyngitis Drug Sales by Country (2024-2029) & (K Units)
Table 110. Genentech Inc Company Information
Table 111. Genentech Inc Description and Major Businesses
Table 112. Genentech Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Genentech Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Genentech Inc Recent Developments
Table 115. Adamas Pharmaceutical Inc Company Information
Table 116. Adamas Pharmaceutical Inc Description and Major Businesses
Table 117. Adamas Pharmaceutical Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Adamas Pharmaceutical Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Adamas Pharmaceutical Inc Recent Developments
Table 120. PLIVA HRVATSKA d.o.o Company Information
Table 121. PLIVA HRVATSKA d.o.o Description and Major Businesses
Table 122. PLIVA HRVATSKA d.o.o Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. PLIVA HRVATSKA d.o.o Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. PLIVA HRVATSKA d.o.o Recent Developments
Table 125. Pfizer Inc Company Information
Table 126. Pfizer Inc Description and Major Businesses
Table 127. Pfizer Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Pfizer Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Pfizer Inc Recent Developments
Table 130. Valeant Pharmaceuticals International, Inc Company Information
Table 131. Valeant Pharmaceuticals International, Inc Description and Major Businesses
Table 132. Valeant Pharmaceuticals International, Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Valeant Pharmaceuticals International, Inc Recent Developments
Table 135. Mylan N.V Company Information
Table 136. Mylan N.V Description and Major Businesses
Table 137. Mylan N.V Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Mylan N.V Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Mylan N.V Recent Developments
Table 140. GSK group of companies Company Information
Table 141. GSK group of companies Description and Major Businesses
Table 142. GSK group of companies Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. GSK group of companies Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. GSK group of companies Recent Developments
Table 145. Teva Pharmaceutical Industries Ltd Company Information
Table 146. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 147. Teva Pharmaceutical Industries Ltd Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Teva Pharmaceutical Industries Ltd Recent Developments
Table 150. AbbVie Inc Company Information
Table 151. AbbVie Inc Description and Major Businesses
Table 152. AbbVie Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. AbbVie Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. AbbVie Inc Recent Developments
Table 155. Viatris Inc. (Mylan) Company Information
Table 156. Viatris Inc. (Mylan) Description and Major Businesses
Table 157. Viatris Inc. (Mylan) Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Viatris Inc. (Mylan) Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Viatris Inc. (Mylan) Recent Developments
Table 160. GlaxoSmithKline plc Company Information
Table 161. GlaxoSmithKline plc Description and Major Businesses
Table 162. GlaxoSmithKline plc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. GlaxoSmithKline plc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. GlaxoSmithKline plc Recent Developments
Table 165. Abbott Laboratories Company Information
Table 166. Abbott Laboratories Description and Major Businesses
Table 167. Abbott Laboratories Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Abbott Laboratories Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Abbott Laboratories Recent Developments
Table 170. Amgen Inc Company Information
Table 171. Amgen Inc Description and Major Businesses
Table 172. Amgen Inc Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Amgen Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Amgen Inc Recent Developments
Table 175. Sanofi-aventis Groupe Company Information
Table 176. Sanofi-aventis Groupe Description and Major Businesses
Table 177. Sanofi-aventis Groupe Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Sanofi-aventis Groupe Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Sanofi-aventis Groupe Recent Developments
Table 180. Purdue Pharma L.P Company Information
Table 181. Purdue Pharma L.P Description and Major Businesses
Table 182. Purdue Pharma L.P Pharyngitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Purdue Pharma L.P Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Purdue Pharma L.P Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Pharyngitis Drug Distributors List
Table 188. Pharyngitis Drug Customers List
Table 189. Pharyngitis Drug Market Trends
Table 190. Pharyngitis Drug Market Drivers
Table 191. Pharyngitis Drug Market Challenges
Table 192. Pharyngitis Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharyngitis Drug Product Picture
Figure 2. Global Pharyngitis Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pharyngitis Drug Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Spray Product Picture
Figure 7. Solution Product Picture
Figure 8. Other Product Picture
Figure 9. Global Pharyngitis Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Pharyngitis Drug Market Share by Application in 2022 & 2029
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Pharyngitis Drug Report Years Considered
Figure 15. Global Pharyngitis Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Pharyngitis Drug Revenue 2018-2029 (US$ Million)
Figure 17. Global Pharyngitis Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Pharyngitis Drug Revenue Market Share by Region (2018-2029)
Figure 19. Global Pharyngitis Drug Sales 2018-2029 ((K Units)
Figure 20. Global Pharyngitis Drug Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Pharyngitis Drug Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Pharyngitis Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Pharyngitis Drug Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Pharyngitis Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Pharyngitis Drug Sales YoY (2018-2029) & (K Units)
Figure 26. China Pharyngitis Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Pharyngitis Drug Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Pharyngitis Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Pharyngitis Drug Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Pharyngitis Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Pharyngitis Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Pharyngitis Drug in the World: Market Share by Pharyngitis Drug Revenue in 2022
Figure 33. Global Pharyngitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Pharyngitis Drug Sales Market Share by Type (2018-2029)
Figure 35. Global Pharyngitis Drug Revenue Market Share by Type (2018-2029)
Figure 36. Global Pharyngitis Drug Sales Market Share by Application (2018-2029)
Figure 37. Global Pharyngitis Drug Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Pharyngitis Drug Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Pharyngitis Drug Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Pharyngitis Drug Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Pharyngitis Drug Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Pharyngitis Drug Revenue Share by Country (2018-2029)
Figure 43. US & Canada Pharyngitis Drug Sales Share by Country (2018-2029)
Figure 44. U.S. Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Pharyngitis Drug Sales Market Share by Type (2018-2029)
Figure 47. Europe Pharyngitis Drug Revenue Market Share by Type (2018-2029)
Figure 48. Europe Pharyngitis Drug Sales Market Share by Application (2018-2029)
Figure 49. Europe Pharyngitis Drug Revenue Market Share by Application (2018-2029)
Figure 50. Europe Pharyngitis Drug Revenue Share by Country (2018-2029)
Figure 51. Europe Pharyngitis Drug Sales Share by Country (2018-2029)
Figure 52. Germany Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 53. France Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 57. China Pharyngitis Drug Sales Market Share by Type (2018-2029)
Figure 58. China Pharyngitis Drug Revenue Market Share by Type (2018-2029)
Figure 59. China Pharyngitis Drug Sales Market Share by Application (2018-2029)
Figure 60. China Pharyngitis Drug Revenue Market Share by Application (2018-2029)
Figure 61. Asia Pharyngitis Drug Sales Market Share by Type (2018-2029)
Figure 62. Asia Pharyngitis Drug Revenue Market Share by Type (2018-2029)
Figure 63. Asia Pharyngitis Drug Sales Market Share by Application (2018-2029)
Figure 64. Asia Pharyngitis Drug Revenue Market Share by Application (2018-2029)
Figure 65. Asia Pharyngitis Drug Revenue Share by Region (2018-2029)
Figure 66. Asia Pharyngitis Drug Sales Share by Region (2018-2029)
Figure 67. Japan Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 71. India Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Pharyngitis Drug Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Pharyngitis Drug Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Pharyngitis Drug Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Pharyngitis Drug Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Pharyngitis Drug Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Pharyngitis Drug Sales Share by Country (2018-2029)
Figure 78. Brazil Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Pharyngitis Drug Revenue (2018-2029) & (US$ Million)
Figure 83. Pharyngitis Drug Value Chain
Figure 84. Pharyngitis Drug Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed